Screening tool boosts survival rate of children with ALL

03/12/2013 | Sydney Morning Herald (Australia), The

A test designed to detect even the smallest trace of diseased cells found in the bone marrow of children with acute lymphoblastic leukemia can determine the risk of possible relapses ahead of time, according to a study in the journal Leukaemia. Australian researchers used the test in 1,000 pediatric ALL patients and found the method increased the survival rate to 75% and saved the lives of approximately 30 to 40 children.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA